Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00032063
DRKS00032063
Recruiting
Not Applicable

Effect of Extracorporeal membrane oxygenation flow on Venous Congestion and abdominal Organ Perfusion - EVeCo

niversitätsmedizin Göttingen0 sites70 target enrollmentAugust 21, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsJ80.0

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
J80.0
Sponsor
niversitätsmedizin Göttingen
Enrollment
70
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 21, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsmedizin Göttingen

Eligibility Criteria

Inclusion Criteria

  • •Extracorporeal membrane oxygenation
  • •\- Age \> 18 years \< 70 years
  • •\- Deep sedation (RASS score \-4/\-5\)
  • •\- Arterial blood pressure measurement for clinical indication
  • •\- Central venous catheter for clinical indication
  • •\- ECMO blood flow of only 2 liters required for gas exchange

Exclusion Criteria

  • •\- Age \< 18 years \> 70 years
  • •\- Lack of consent
  • •\- Renal artery stenosis
  • •\- Known liver disease (e.g. cirrhosis, chronic hepatitis)
  • •\- Portal hypertension
  • •\- Increased intra\-abdominal pressure
  • •\- Post\-nephrectomy/splenectomy/liver surgery (excluding cholecystectomy)
  • •\- Impaired renal function (eGFR \< 60 ml/min/1\.73m3\)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Pilot study investigating how Extracorporeal Membrane Oxygenation (ECMO) affects the major breathing muscles.Diaphragm atrophyECMOMusculoskeletal - Other muscular and skeletal disordersRespiratory - Other respiratory disorders / diseases
ACTRN12616000944437Trent Donnelly20
Not yet recruiting
Not Applicable
itric Oxide on ExtraCorporeal Membrane Oxygenation – a randomised Trial in neonates and children (NECTAR trial).Cardiovascular failure requiring Extracorporeal Membrane OxygenationRespiratory failure requiring Extracorporeal Membrane OxygenationRespiratory - Other respiratory disorders / diseasesCardiovascular - Other cardiovascular diseases
ACTRN12619001518156The University of Queensland50
Recruiting
Not Applicable
nderstanding Extracorporal Membrane Oxygenation Induced Coaguloapathy – A Prospective Cohort Study in the Intensive Care Unit (EXTRICATE)In VV-ECMO patients with severe ARDSin VA-ECMO patients with cardiac arrest during ongoing resuscitation.
DRKS00033769niversität Witten/Herdecke & Klinik Köln Merheim50
Completed
Not Applicable
Extracorporeal membrane oxygenation in patients with coronavirus disease 2019PCR-proven COVID-19, resulting in respiratory or cardiorespiratory insufficiency, refractory to conventional therapies.
NL-OMON27273/A200
Completed
Not Applicable
Extracorporeal membrane oxygenation in adults: a retrospective analysis of differences in indication, morbidity and mortality in a single-centre observational study.Extracorporal membrane oxygenationR57.0R57.2J80Cardiogenic shockSeptic shockAdult respiratory distress syndrome
DRKS00014629Asklepios Klinik Langen131